97 related articles for article (PubMed ID: 1673985)
1. Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide.
Buckley TL; Brain SD; Collins PD; Williams TJ
J Immunol; 1991 May; 146(10):3424-30. PubMed ID: 1673985
[TBL] [Abstract][Full Text] [Related]
2. Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
Van Osselaer N; Van Damme J; Rampart M; Herman AG
Am J Pathol; 1991 Jan; 138(1):23-7. PubMed ID: 1824807
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation.
Buckley TL; Brain SD; Rampart M; Williams TJ
Br J Pharmacol; 1991 Jun; 103(2):1515-9. PubMed ID: 1884106
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the acetylcholine- and substance P-induced pulmonary edema by calcitonin gene-related peptide in the rabbit.
Delaunois A; Gustin P; Ansay M
J Pharmacol Exp Ther; 1994 Jul; 270(1):30-6. PubMed ID: 7518513
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13 - 52) to modulate microvascular but not thermal hyperalgesia responses.
Chu DQ; Choy M; Foster P; Cao T; Brain SD
Br J Pharmacol; 2000 Aug; 130(7):1589-96. PubMed ID: 10928962
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
Brain SD; Williams TJ
Br J Pharmacol; 1985 Dec; 86(4):855-60. PubMed ID: 2416378
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin gene-related peptide enhances cytokine-induced IL-6 production by fibroblasts.
Sakuta H; Inaba K; Muramatsu S
Cell Immunol; 1995 Oct; 165(1):20-5. PubMed ID: 7671321
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
9. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin.
Hughes SR; Brain SD
Br J Pharmacol; 1991 Nov; 104(3):738-42. PubMed ID: 1797334
[TBL] [Abstract][Full Text] [Related]
10. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
11. Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw.
Bileviciute I; Stenfors C; Theodorsson E; Lundeberg T
Br J Pharmacol; 1998 Nov; 125(6):1304-12. PubMed ID: 9863661
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions between neuropeptide and histamine on the capillary permeability in rat skin: evaluation by reflectance spectrophotometry.
Kakizoe E; Kobayashi Y; Gonda T; Shimoura K; Hattori K; Okunishi H
Microvasc Res; 1997 Jul; 54(1):27-34. PubMed ID: 9245641
[TBL] [Abstract][Full Text] [Related]
13. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin.
Hellewell PG; Williams TJ
J Immunol; 1986 Jul; 137(1):302-7. PubMed ID: 2940300
[TBL] [Abstract][Full Text] [Related]
14. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Liu C; Chen X; Jin Y; Qu R; Jiang PF; Wen GM; Tang ZH
Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
Angle MJ; McManus LM; Pinckard RN
Lab Invest; 1986 Dec; 55(6):616-21. PubMed ID: 3465972
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide inhibits interleukin-1beta-induced interleukin-8 secretion in human type II alveolar epithelial cells.
Li WJ; Wang TK
Acta Pharmacol Sin; 2006 Oct; 27(10):1340-5. PubMed ID: 17007741
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo.
Warren JB; Larkin SW; Coughlan M; Kajekar R; Williams TJ
Br J Pharmacol; 1992 Jun; 106(2):331-4. PubMed ID: 1393266
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
20. Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp.
Maltos KL; Menezes GB; Caliari MV; Rocha OA; Santos JM; Alves DL; Duarte ID; Francischi JN
Arch Oral Biol; 2004 Jun; 49(6):443-50. PubMed ID: 15099801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
